Qi Lu - Publications

Cryoballoon ablation versus antiarrhythmic drug therapy as initial treatment for persistent atrial fibrillation: the multicenter randomized CEPAF trial.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: May 11, 2026

Mocetinostat Ameliorates Pathological Cardiac Hypertrophy via Suppression of Ferroptosis Through Nrf2 Pathway.

Journal: Die Pharmazie

Published: March 09, 2026

TAX1BP1 protects against doxorubicin-induced cardiotoxicity via maintaining mitochondrial function in a mTORC2-SGK1-VDAC1 manner.

Journal: Molecular medicine (Cambridge, Mass.)

Published: February 18, 2025

Hydrogel membranes in organ-on-a-chip devices: A review.

Journal: Colloids and surfaces. B, Biointerfaces

Published: January 03, 2025

TBC1D15 protects alcohol-induced liver injury in female mice through PLIN5-mediated mitochondrial and lipid droplet contacting.

Journal: Metabolism: clinical and experimental

Published: November 13, 2024

Metallothionein rescues doxorubicin cardiomyopathy via mitigation of cuproptosis.

Journal: Life sciences

Published: October 16, 2024

The predictive value of pan-immune inflammatory index for early recurrence of atrial fibrillation after cryoablation.

Journal: BMC cardiovascular disorders

Published: July 05, 2024

DHODH Alleviates Heart Failure via the Modulation of CoQ-Related Ferroptotic Inhibition.

Journal: Frontiers in bioscience (Landmark edition)

Published: March 06, 2024

Elevated levels of alcohol dehydrogenase aggravate ethanol-evoked cardiac remodeling and contractile anomalies through FKBP5-yap-mediated regulation of ferroptosis and ER stress.

Journal: Life sciences

Published: December 13, 2023

The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial.

Journal: Nature medicine

Published: November 28, 2023

Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.

Journal: Cancer metastasis reviews

Published: July 31, 2023

Bioresponsive and multifunctional cyclodextrin-based non-viral nanocomplexes in cancer therapy: Building foundations for gene and drug delivery, immunotherapy and bioimaging.

Journal: Environmental research

Published: May 23, 2023